Turn Therapeutics Inc. (TTRX) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Turn Therapeutics Inc. (TTRX) closed at USD 11.11 on 2026-10-14, a change of +111.6 % over the past year, with a market capitalization of USD 351.96M.

Turn Therapeutics Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Turn Therapeutics Inc. key figures

Previous close

USD 11.11 (2026-10-14)

1-year change

+111.6 %

Market cap

USD 351.96M

Enterprise value

USD 341.08M

P/E ratio (trailing)

-37.39

P/E ratio (forward)

-77.27

EPS (trailing)

-0.31

EPS (forward)

-0.15

PEG ratio

n/a

Price to book

503.91

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

1.61

Employees

2

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Turn Therapeutics Inc.

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Turn Therapeutics Inc. and compare it with other stocks.